Arkolith/Insider Trading/HALO/Form 4

Krishnan Mahesh

DirectorHALOZYME THERAPEUTICS, INC. (HALO) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$548K
Net Open-Market Flow
-$548K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)7K$38.46$281K22K
Jun 29, 2026Sell(S)7K$75.00$548K14K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)7K—$02K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001159036-26-000082) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML